{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T03:46:29Z","timestamp":1772250389480,"version":"3.50.1"},"reference-count":15,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T00:00:00Z","timestamp":1749772800000},"content-version":"vor","delay-in-days":12,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["eJHaem"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Outcomes for patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) that have progression after treatment with hypomethylating agent (HMA) and venetoclax (VEN) are poor. However, data for chemotherapy and VEN (C+VEN) therapy after prior treatment with HMA+VEN are limited.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We identified 18 patients with AML or MDS\/AML who received C+VEN after prior HMA+VEN.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Complete remission (CR) or CR with incomplete hematologic recovery (CRi) was achieved in 7 patients (39%) and 6 patients (33%) proceeded to allogeneic hematopoietic stem cell transplantation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study shows suggests that C+VEN could be a viable option in a subset of patients after HMA+VEN.<\/jats:p><\/jats:sec>","DOI":"10.1002\/jha2.70078","type":"journal-article","created":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T08:19:48Z","timestamp":1749802788000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Outcomes for Patients With Myeloid Neoplasms Treated With Chemotherapy Plus Venetoclax After Prior Venetoclax Therapy"],"prefix":"10.1002","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-9243-2662","authenticated-orcid":false,"given":"Rafael","family":"Madero\u2010Marroquin","sequence":"first","affiliation":[{"name":"Section of Hematology\/Oncology Department of Medicine University of Chicago  Chicago Illinois USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Cannova","sequence":"additional","affiliation":[{"name":"Section of Hematology\/Oncology Department of Medicine University of Chicago  Chicago Illinois USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Dworkin","sequence":"additional","affiliation":[{"name":"Department of Pharmacy University of Chicago Medicine  Chicago Illinois USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Austin","family":"Wesevich","sequence":"additional","affiliation":[{"name":"Section of Hematology\/Oncology Department of Medicine University of Chicago  Chicago Illinois USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory W.","family":"Roloff","sequence":"additional","affiliation":[{"name":"Section of Hematology\/Oncology Department of Medicine University of Chicago  Chicago Illinois USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caner","family":"Saygin","sequence":"additional","affiliation":[{"name":"Section of Hematology\/Oncology Department of Medicine University of Chicago  Chicago Illinois USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariam T.","family":"Nawas","sequence":"additional","affiliation":[{"name":"Section of Hematology\/Oncology Department of Medicine University of Chicago  Chicago Illinois USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam S.","family":"DuVall","sequence":"additional","affiliation":[{"name":"Section of Hematology\/Oncology Department of Medicine University of Chicago  Chicago Illinois USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satyajit","family":"Kosuri","sequence":"additional","affiliation":[{"name":"Section of Hematology\/Oncology Department of Medicine University of Chicago  Chicago Illinois USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Thirman","sequence":"additional","affiliation":[{"name":"Section of Hematology\/Oncology Department of Medicine University of Chicago  Chicago Illinois USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olatoyosi","family":"Odenike","sequence":"additional","affiliation":[{"name":"Section of Hematology\/Oncology Department of Medicine University of Chicago  Chicago Illinois USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy","family":"Stock","sequence":"additional","affiliation":[{"name":"Section of Hematology\/Oncology Department of Medicine University of Chicago  Chicago Illinois USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard A.","family":"Larson","sequence":"additional","affiliation":[{"name":"Section of Hematology\/Oncology Department of Medicine University of Chicago  Chicago Illinois USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael W.","family":"Drazer","sequence":"additional","affiliation":[{"name":"Section of Hematology\/Oncology Department of Medicine University of Chicago  Chicago Illinois USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0296-8686","authenticated-orcid":false,"given":"Anand A.","family":"Patel","sequence":"additional","affiliation":[{"name":"Section of Hematology\/Oncology Department of Medicine University of Chicago  Chicago Illinois USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2025,6,13]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bneo.2024.100038"},{"key":"e_1_2_8_3_1","first-page":"1","article-title":"Response to Intensive Induction Chemotherapy After Failure of Frontline Azacitidine and Venetoclax in Acute Myeloid Leukemia","author":"Gil K. B.","year":"2024","journal-title":"Leukemia & Lymphoma"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2024.107577"},{"key":"e_1_2_8_5_1","doi-asserted-by":"crossref","unstructured":"L.Ruhnke C.Schliemann J.\u2010H.Mikesch et\u00a0al.Venetoclax\u2010Based Salvage Treatment for Relapsed\/Refractory AML Using a Combination With High\u2010Dose Cytarabine and Mitoxantrone (HAM\u2010VEN): Updated Results of the Phase\u2010I\/II SAL Relax Trial.Blood142 (2024): 160.","DOI":"10.1182\/blood-2023-184445"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.03736"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-024-00982-3"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2024026700"},{"issue":"8","key":"e_1_2_8_9_1","first-page":"2706","article-title":"Cladribine Plus Cytarabine Plus Venetoclax in Acute Myeloid Leukemia Relapsed or Refractory to Venetoclax Plus Hypomethylating Agent","volume":"109","author":"Steinauer N.","year":"2024","journal-title":"Haematologica"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2024027217"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022015850"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022016867"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2004.05094.x"},{"key":"e_1_2_8_14_1","article-title":"Menin Inhibition With Revumenib for KMT2A\u2010rearranged Relapsed or Refractory Acute Leukemia (AUGMENT\u2010101)","author":"Issa G. C.","year":"2024","journal-title":"Journal of Clinical Oncology"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2024025409"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-025-02531-8"}],"container-title":["eJHaem"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jha2.70078","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T13:23:04Z","timestamp":1750684984000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jha2.70078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["10.1002\/jha2.70078"],"URL":"https:\/\/doi.org\/10.1002\/jha2.70078","archive":["Portico"],"relation":{},"ISSN":["2688-6146","2688-6146"],"issn-type":[{"value":"2688-6146","type":"print"},{"value":"2688-6146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"2025-03-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70078"}}